QuidelOrtho (QDEL) Capital Expenditures (2021 - 2026)

QuidelOrtho has disclosed Capital Expenditures across 6 years of filings, most recently posting $34.0 million for Q1 2026.

• Capital Expenditures for Q1 2026 came in at $34.0 million, down 39.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $166.0 million (down 10.37% YoY), and the FY2025 annual result was $188.2 million, down 3.54% from the prior year.
• Capital Expenditures came in at $34.0 million for Q1 2026 at QuidelOrtho, down from $45.3 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $66.1 million in Q1 2024 to a low of -$119.5 million in Q1 2023.
• The 5-year median for Capital Expenditures is $46.5 million (2024), against an average of $35.3 million.
• Across the five-year window, Capital Expenditures jumped 193.33% in 2023 and plunged 39.5% in 2026, its largest moves.
• QuidelOrtho's Capital Expenditures stood at $22.5 million in 2022, then jumped by 116.0% to $48.6 million in 2023, then fell by 2.88% to $47.2 million in 2024, then fell by 4.03% to $45.3 million in 2025, then retreated by 24.94% to $34.0 million in 2026.
• The last three Capital Expenditures figures came in at $34.0 million (Q1 2026), $45.3 million (Q4 2025), and $49.2 million (Q3 2025), per Business Quant data.